APA

Hall I. H., Barnes B. J., Ward E. S., Wheaton J. R., Warren A. E. & Izydore R. A. (20010614). Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones. : Archiv der Pharmazie.

Chicago

Hall I H, Barnes B J, Ward E S, Wheaton J R, Warren A E and Izydore R A. 20010614. Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones. : Archiv der Pharmazie.

Harvard

Hall I. H., Barnes B. J., Ward E. S., Wheaton J. R., Warren A. E. and Izydore R. A. (20010614). Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones. : Archiv der Pharmazie.

MLA

Hall I H, Barnes B J, Ward E S, Wheaton J R, Warren A E and Izydore R A. Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones. : Archiv der Pharmazie. 20010614.